Symrise invests in enzymatic tech for “rare” sugar alternatives by start-up Bonumose
date:Jul 19, 2023
utrition Health segment within its North American business.

Ed Rogers, CEO and co-founder of Bonumose, says the companys enzymatic technology breakthrough for producing affordable, delicious, healthy tagatose, is growing, and the company has developed methods for making additional affordable ingredients, such as allulose, allose and D-mannose, among others.

There is a rising demand for products that retain a favorable taste but limit sugar content because of the escalating rates of obesity an
2/8 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
01/14 22:00